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Abstract
Introduction: Congenital hepatic fibrosis is an uncommon cause of portal hypertension. Despite the presence of
portal hypertension, hepatocellular and renal function are usually well preserved. Congenital hepatic fibrosis is
included in the group of congenital diseases of fibropolycystic disorders. These include a broad spectrum of clinical
diseases which are usually accompanied by hepatic involvement.
Case presentation: We report the case of a 27-year-old Iranian woman with congenital hepatic fibrosis leading to
cirrhosis and subsequently hepatocellular carcinoma.
Conclusion: Advanced cirrhosis was diagnosed and our patient was scheduled for liver transplantation. During
preparation for transplant, a hepatic mass was discovered which was found to be hepatocellular carcinoma.
Radiofrequency ablation was performed and our patient was referred for transplantation.
Introduction
Congenital hepatic fibrosis (CHF) is an uncommon
cause of portal hypertension. Despite the presence of
portal hypertension, hepatocellular and renal function
are usually well preserved. CHF is included in the group
of congenital diseases of fibropolycystic disorders. These
include a broad spectrum of clinical diseases which are
usually accompanied by hepatic involvement.
Hepatocellular carcinoma (HCC) is a rare complica-
tion of CHF with only a few previous cases reported.
We report the case of a 27-year-old woman with CHF
who developed cirrhosis and HCC. Advanced cirrhosis
was diagnosed and our patient was scheduled for liver
transplantation. During preparation for transplant, a
hepatic mass was discovered which was proved to be
HCC. Radiofrequency ablation was performed and our
patient was referred for transplantation.
Case presentation
A 27-year-old Iranian woman was admitted to our hos-
pital for evaluation of worsening hepatic function. She
first came to medical attention at the age of 10 when
hepatosplenomegaly was noted incidentally on a routine
physical examination at another hospital, so she was
admitted to undergo further examination. Her liver
function was found to be within normal limits as was
her renal function. Both her growth and development
were normal for her age. However, hepatomegaly and
splenomegaly were noted. A liver biopsy revealed prolif-
eration of collagen fibers surrounding the portal area, a
finding that was compatible with congenital hepatic
fibrosis. Our patient had no history of hematemesis or
tarry stool, but esophageal varices were detectable
beginning at 10 years of age. Propranolol was started
but she discontinued her medication after a couple of
months despite medical advice.
Our patient was followed regularly without any com-
plications such as abdominal pain, jaundice, hematem-
esis, tarry stool, or increases in liver enzymes. No
history could be elicited of alcohol abuse or previous
hepatitis. There was no family history of liver or kidney
disease. Markers for hepatitis B and C were negative;
urine and serum copper levels were normal; and serum
auto-antibodies were negative. The liver size gradually
decreased and portal pressure increased as documented
by ultrasonography and computed tomography (CT)
(Figure 1). Her portal vein diameter was 14 mm, and
splenomegaly was observed. Grade 1 lower esophageal
varices were reported during an upper gastrointestinal
endoscopy. Our patient was put on a waiting list for
liver transplantation.
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mass was observed in her right liver lobe, which was
unnoted in previous evaluations (Figure 2). A percuta-
neous liver biopsy was reported to demonstrate HCC.
Her serum alpha fetoprotein (AFP) level was 1900 IU/
ml (normal < 6 IU/ml), serum glutamic oxaloacetic
transaminase 72 IU/L, serum glutamic pyruvic transami-
nase 39 IU/L, alkaline phosphatise 120 IU/L, total biliru-
bin 3.2 mg/dL, direct bilirubin 2.3 mg/dL, albumin 2.7
g/dL, prothrombin time 16.1 seconds and her interna-
tional normalized ratio 1.44.
She was removed from the transplantation waiting list
and was admitted for staging and planning treatment
strategies. During admission, she developed abdominal
pain, worsening abdominal distention and hepatic ence-
phalopathy. Because of a decreased level of conscious-
ness and seizure, a brain CT scan was done which
revealed unexpected left hemispheric atrophy with
severe dilation of her left ventricle (Figure 3). Proper
management accompanied by frequent abdominal para-
centesis led to partial improvement.
Following radiofrequency ablation, the tumor size
declined to about 25 mm with central necrosis (Figure
4) and our patient was enrolled on to the liver trans-
plantation waiting list again.
Discussion
Congenital hepatic fibrosis is defined pathologically by
bands of fibrous tissue within the liver, linking the
Figure 1 Heterogeneous and cirrhotic liver in CT scan.
Figure 2 a 59 × 39 mm mass in the right liver lobe.
Figure 3 Left hemispheric atrophy with severe dilation of the
left ventricle.
Figure 4 Following radiofrequency ablation, tumor size
declined.
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occurs in association with a range of inherited disorders
involving the kidneys. Although infantile-type polycystic
kidney disease is usually an autosomal recessive disor-
der, our patient in the present report represents a spora-
dic case. Clinically, congenital hepatic fibrosis is
characterized by portal hypertension with well-preserved
liver function [1]. In adults, the disease is associated
with two major risks: gastrointestinal hemorrhage
caused by portal hypertension, and cholangitis due to
bacterial infection of dilated intra-hepatic bile ducts.
These episodes are sometimes fatal. The age at onset of
symptoms may be as young as three to six months [2,3].
The usual age of presentation is between 1.8 and 14
years [4]. Tubular renal dysfunction is present in less
than 10% of patients. This usually has no clinical mani-
festation, except in the presence of portal hypertension
or cholangitis [5]. Ockendens divided his patients into
four age groups: perinatal, neonatal, infantile, and ado-
lescent. The highest prevalence of renal involvement
was noted in the perinatal group and lowest in the ado-
lescent group [6]. The highest prevalence of cholangitis
was reported in the adolescent group.
Our patient was in the adolescent group, but no epi-
sodes of cholangitis were found. Our patient had no his-
tory of fever and jaundice, nor any evidence of
cholangitis; however, she developed cirrhosis and hepa-
tic failure which necessitated liver transplantation.
Therefore, we could not explain the cause of cirrhosis
by repeated cholangitis.
CHF is closely associated with neonatal polycystic kid-
ney disease and dilation of the intrahepatic biliary tree
(Caroli’s Disease). Other disorders associated with CHF
are medullary sponge kidney, Ivemark familial dysplasia,
Meckel syndrome, vaginal atresia, and with less preva-
lence in adults, polycystic kidney, and tuberous sclerosis
[7].
Although these conditions had been ruled out in our
patient, the severe dilation of her brain ventricles, espe-
cially in her left lateral ventricle due to left hemispheric
atrophy, remains of special interest. Our case may add
another new category to these known clinical types of
CHF, which include cirrhosis, HCC, and unusual extra-
hepatic manifestations in the brain. However, more
cases should be studied before a definite conclusion can
be made.
A diagnosis of CHF is suggested when normal hepato-
cellular function is associated with hypersplenism and
increased levels of alkaline phosphatase and gamma glu-
tamyl transferase [8]. Definite diagnosis is by liver
biopsy [4]. Prognosis is dependent on the degree of por-
tal hypertension, the signs and symptoms of which can
be decreased by surgical shunts [1]. As mentioned, CHF
distorts the hepatic structure without any effect on
hepatocellular function, so levels of liver enzymes are
generally within normal ranges. In cirrhosis, in contrast
to CHF, hepatocellular injury occurs and the abnormal
level of liver enzymes is a distinctive feature [9]. The
question is whether CHF could be a precursor to liver
cirrhosis? In the search for diverse causes of liver cirrho-
sis, CHF has not previously been considered [10]. This
is despite a few cases reporting an association between
CHF and cirrhosis [11].
Conclusion
We propose that there be a high index of suspicion for
the development of HCC in patients with CHF, particu-
larly in those presenting with jaundice and cirrhosis.
Screening could be undertaken with serum AFP mea-
surements and hepatic imaging studies, using ultra-
sound, CT, or magnetic resonance imaging.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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